Genstar to sell ERT to Nordic Capital

Genstar Capital agreed to sell ERT, a Philadelphia-based provider of patient data collection solutions for use in clinical drug development, to Nordic Capital. Financial terms of the transaction were not disclosed. Genstar acquired ERT in 2012 for approximately $400 million in a take-private transaction.

DealsNorth AmericaUSBriefs